Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
- SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
PHILADELPHIA--(BUSINESS WIRE)--In response to the pharmaceutical giant Mallinckrodt's bankruptcy filing last week, Delaware Valley Health Care Coalition, Inc. (DVHCC) President John Heenan said, "Its crucial for our members to have a seat at the table for the bankruptcy proceedings."
The DVHCC is a non-profit voluntary association comprised of multi-employer trust funds, governmental entities, labor unions, schools and school districts in over fourteen states and the District of Columbia.
Three of DVHCCs members have sued Mallinckrodt for their pricing scheme of the drug H.P. Acthar Gel. The drug cost just $40 a vial in 2001 and today costs $46,000 per vial.
More on The PennZone
H.P. Acthar Gel is a hormone used to treat conditions such as multiple sclerosis. It can reduce the symptoms but it is not a cure for these conditions.
Last week, Mallinckrodt filed for bankruptcy putting a stay on the current lawsuits in an attempt to avoid liability for its pricing scheme. Henry Donner, DVHCC Counsel said, "We are asking the Bankruptcy Trustee to include a representative from our litigation on the bankruptcy committee – which will decide, among other things, how unsecured creditors are paid."
Among the DVHCC members who have sued Mallinckrodt and are owed hundreds of millions of dollars are the Steamfitters Local 420, Operating Engineers Local 542 and Plumbers Local 322.
The DVHCC is a non-profit voluntary association comprised of multi-employer trust funds, governmental entities, labor unions, schools and school districts in over fourteen states and the District of Columbia.
Three of DVHCCs members have sued Mallinckrodt for their pricing scheme of the drug H.P. Acthar Gel. The drug cost just $40 a vial in 2001 and today costs $46,000 per vial.
More on The PennZone
- KDG Recognized on the Clutch 1000 List for 2025
- SNS Research Group has published its flagship report, "Dermatological Drugs Market: 2025–2035"
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- The Rise of Experience Gifting: Families Choosing Memories Over More Stuff This Christmas
H.P. Acthar Gel is a hormone used to treat conditions such as multiple sclerosis. It can reduce the symptoms but it is not a cure for these conditions.
Last week, Mallinckrodt filed for bankruptcy putting a stay on the current lawsuits in an attempt to avoid liability for its pricing scheme. Henry Donner, DVHCC Counsel said, "We are asking the Bankruptcy Trustee to include a representative from our litigation on the bankruptcy committee – which will decide, among other things, how unsecured creditors are paid."
Among the DVHCC members who have sued Mallinckrodt and are owed hundreds of millions of dollars are the Steamfitters Local 420, Operating Engineers Local 542 and Plumbers Local 322.
Filed Under: Business
0 Comments
Latest on The PennZone
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Discover the Magic of Creativity with The Balance of Brushes and Bytes
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- BPM Systems Launches New Automated Packaging & Labeling Solution for Manufacturers Across The US
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- Zac Arbitman Elected As Co-Chair of Philadelphia Bar Association Federal Courts Committee
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI